NSE adds dummy Ennature Bio Pharma, IGL Spirits listings to Nifty indices after India Glycols demerger
Reuters2026/08/26 13:08- NSE set a special pre-open session for India Glycols on Sep. 2, 2026 due to a two-way demerger.
- BioPharma unit to be spun off into Ennature Bio Pharma; Spirits and Biofuel unit to be separated into IGL Spirits.
- Ennature Bio Pharma and IGL Spirits to enter select Nifty indices at zero price with equal weights, effective Sep. 2.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Crypto prices
More
